FRONTIER Executive Screen: a brief executive battery to differentiate frontotemporal dementia and Alzheimer's disease

@article{Leslie2015FRONTIERES,
  title={FRONTIER Executive Screen: a brief executive battery to differentiate frontotemporal dementia and Alzheimer's disease},
  author={F. Leslie and D. Foxe and N. Daveson and E. Flannagan and J. Hodges and O. Piguet},
  journal={Journal of Neurology, Neurosurgery & Psychiatry},
  year={2015},
  volume={87},
  pages={831 - 835}
}
  • F. Leslie, D. Foxe, +3 authors O. Piguet
  • Published 2015
  • Medicine
  • Journal of Neurology, Neurosurgery & Psychiatry
    • Background and objective Executive dysfunctions are a key clinical feature of behavioural-variant frontotemporal dementia (bvFTD). Such deficits are also found in Alzheimer's disease (AD), making the differentiation between these two diseases difficult at times, particularly in the absence of extensive cognitive assessments. To address this issue, we developed the FRONTIER Executive Screen (FES), which combines three abbreviated measures of verbal fluency, inhibitory control and working memory… CONTINUE READING
    View on BMJ
    sydney.edu.au
    19 Citations
    Background Citations
    2
    Methods Citations
    1

    Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    19 Citations
    Citation Type

    Citation Type

    Disinhibition in Frontotemporal Dementia and Alzheimer's Disease: A Neuropsychological and Behavioural Investigation.
    • 2
    • PDF
    The behavioral dyscontrol scale in the differential diagnosis of behavioral variant of frontotemporal dementia and Alzheimer disease.
    Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.
    • 8
    Assessing Executive Dysfunction in Neurodegenerative Disorders: A Critical Review of Brief Neuropsychological Tools
    • 19
    • PDF
    Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia? Review of Key Points Toward an Accurate Clinical and Neuropsychological Diagnosis.
    • 2
    Psychological and Cognitive Markers of Behavioral Variant Frontotemporal Dementia–A Clinical Neuropsychologist's View on Diagnostic Criteria and Beyond
    • 11
    • PDF
    Distinguishing Frontotemporal Dementia From Alzheimer Disease Through Everyday Function Profiles: Trajectories of Change
    Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.
    • 5
    Mental States in Moving Shapes: Distinct Cortical and Subcortical Contributions to Theory of Mind Impairments in Dementia.
    • 21
    • PDF
    Relating constructs of attention and working memory to social withdrawal in Alzheimer’s disease and schizophrenia: issues regarding paradigm selection
    • 5

    References

    SHOWING 1-10 OF 40 REFERENCES
    Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementias
    • 73
    The Frontal Assessment Battery Does Not Differentiate Frontotemporal Dementia from Alzheimer’s Disease
    • 73
    Neuropsychological deficits in frontotemporal dementia and Alzheimer’s disease: a meta-analytic review
    • 156
    • PDF
    Bedside assessment of frontal degeneration: distinguishing Alzheimer's disease from non-Alzheimer's cortical dementia.
    • 51
    Working memory, attention, and executive function in Alzheimer’s disease and frontotemporal dementia
    • 162
    Orbitofrontal Dysfunction Discriminates Behavioral Variant Frontotemporal Dementia from Alzheimer’s Disease
    • 82
    • PDF
    Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia
    • 128
    • PDF
    Clinical Utility of Short Social Cognitive Tests in Early Differentiation of Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease
    • 18
    INECO Frontal Screening (IFS): a brief, sensitive, and specific tool to assess executive functions in dementia.
    • 156
    • PDF
    Examining Executive Dysfunction with the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS): normative values from a healthy sample and clinical utility in Alzheimer's disease.
    • 21
    • PDF